CAGT hero 2

Leaders in Developing and Applying Genomic Technologies

The Genomic Revolution promises the discovery of targeted approaches for treating disease. Innovations like CRISPR-based genome editing and comprehensive epigenomic profiling can inform, streamline and accelerate drug target discoveries, but piecing together this complex puzzle requires an interdisciplinary approach.

The Center for Advanced Genomic Technologies (CAGT) has assembled a team of world-leading engineers, scientists and physicians to integrate these technologies to unravel disease biology and discover new drug targets. By working together, we will catalyze a more robust biotechnology enterprise.

In the News

artistic rendering: paper cutout of a head with a puzzle piece taken out

May 6, 2021 | Duke Center for Genomic and Computational Biology

$8M grant aims to better understand disease mechanisms of schizophrenia

A new $8 million NIH grant seeks to uncover more clues into what genes increase the risk of developing schizophrenia.

COVID virus

April 14, 2021 | Duke Today

Duke-Led Team Finds Why Women May Be Better Equipped to Fight COVID

When it comes to COVID-19, women seem to be the stronger sex

three baboons in the wild

April 6, 2021 | Duke Today

A male baboons dominance gives him babies, but costs him years

Struggle for dominance leaves a mark on genes and speeds up aging